An analysis on the role of glucagon like peptide 1 receptor agonists in cognitive and mental health disorders Nature Mental Health GLP 1 receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal. Read GLP 1 medications can change lives but protein still has to show up. Muscle loss is a real risk without adequate protein intake. Swipe to understand why Pre beef fits perfectly A preliminary study of the physiological and perceptual effects of GLP 1 receptor agonists during alcohol consumption in people with obesity Scientific Reports GLP 1 Elevate